Press Releases

Result of General Meeting and Open Offer and Issue of Equity

C4X Discovery Holdings plc

(“C4XD” or the “Company”)


Result of General Meeting and Open Offer
Issue of Equity

C4X Discovery Holdings plc (AIM: C4XD), a pioneering drug discovery company, today announces that at the General Meeting held earlier today in connection with the Company’s Placing, Subscription and Open Offer, details of which were announced on 24 October 2019, all resolutions put to shareholders were duly passed.

The Company also announces that it has received valid acceptances in respect of 3,907,141 Open Offer Shares from Eligible Shareholders, including applications under the Excess Application Facility. This represents approximately 60.85 per cent. of the 6,421,404 Open Offer Shares offered.

Following the passing of the resolutions at the General Meeting, and conditional on First Admission and Second Admission, the Company has raised £7.59 million (before expenses) in aggregate through the Placing, Subscription and Open Offer.

Applications have been made for the 46,466,667 Placing Shares, 200,000 Subscription Shares and the 3,907,141 Open Offer Shares to be admitted to trading on AIM. It is expected that First Admission of 25,143,330 EIS/VCT Shares will take place at 8.00 a.m. on 14 November 2019 and Second Admission of 21,323,337 General Placing Shares, 200,000 Subscription Shares and 3,907,141 Open Offer Shares will take place at 8.00 a.m. on 15 November 2019. The Placing Shares, Subscription Shares and Open Offer Shares will rank pari passu with the Existing Ordinary Shares.

Following Second Admission, the Company's issued share capital will consist of 108,366,444 Ordinary Shares. There are no Ordinary Shares held in treasury. Therefore, in accordance with the FCA's Disclosure and Transparency Rule 5.6.1, the Company confirms that as at 15 November 2019, the total number of voting rights in the Company will be 108,366,444. Following Second Admission, this figure may be used by shareholders as the denominator for the calculations by which they determine whether they are required to notify their interest in, or a change to their interest in, C4XD under the Disclosure Guidance and Transparency Rules.

The capitalised terms used in this announcement have the meaning as defined in the announcement published by the Company at 7 a.m. on 24 October 2019 unless otherwise stated.

Market Abuse Regulation:

This announcement is released by C4X Discovery Holdings plc and contains inside information for the purposes of the Market Abuse Regulation (EU) 596/2014 (“MAR”) and is disclosed in accordance with the Company’s obligations under Article 17 of MAR.

The person responsible for arranging the release of this information is Clive Dix, CEO of the Company.